Skip to main content

3 Reasons to Sell MATX and 1 Stock to Buy Instead

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

MATX Cover Image

What a fantastic six months it’s been for Matson. Shares of the company have skyrocketed 57.9%, hitting $196.13. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Is there a buying opportunity in Matson, or does it present a risk to your portfolio? Dive into our full research report to see our analyst team’s opinion, it’s free.

Why Is Matson Not Exciting?

Despite the momentum, we’re cautious about Matson. Here are three reasons you should be careful with MATX, plus one stock we’d rather own.

1. Long-Term Revenue Growth Disappoints

Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul. Regrettably, Matson’s sales grew at a tepid 5.2% compounded annual growth rate over the last five years. This fell short of our benchmark for the industrials sector.

Matson Quarterly Revenue

2. Free Cash Flow Margin Dropping

If you’ve followed StockStory for a while, you know we emphasize free cash flow. Why, you ask? We believe that in the end, cash is king, and you can’t use accounting profits to pay the bills.

As you can see below, Matson’s margin dropped by 13.2 percentage points over the last five years. Continued declines could signal it is in the middle of an investment cycle. Matson’s free cash flow margin for the trailing 12 months was 5.1%.

Matson Trailing 12-Month Free Cash Flow Margin

3. New Investments Fail to Bear Fruit as ROIC Declines

ROIC, or return on invested capital, is a metric showing how much operating profit a company generates relative to the money it has raised (debt and equity).

Unfortunately, Matson’s ROIC has decreased significantly over the last few years. We like what management has done in the past, but its declining returns are perhaps a symptom of fewer profitable growth opportunities.

Matson Trailing 12-Month Return On Invested Capital

Final Judgment

Matson isn’t a terrible business, but it doesn’t pass our quality test. After the recent rally, the stock trades at 13.9× forward P/E (or $196.13 per share). While this valuation is fair, the upside isn’t great compared to the potential downside. We’re fairly confident there are better stocks to buy right now. We’d suggest looking at a safe-and-steady industrials business benefiting from an upgrade cycle.

Stocks We Would Buy Instead of Matson

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.39
+6.89 (2.90%)
AAPL  298.01
+2.06 (0.70%)
AMD  537.37
+24.89 (4.86%)
BAC  56.20
-0.33 (-0.58%)
GOOG  367.46
+5.36 (1.48%)
META  577.22
+9.64 (1.70%)
MSFT  379.40
+0.49 (0.13%)
NVDA  210.69
+6.04 (2.95%)
ORCL  184.29
+0.76 (0.41%)
TSLA  400.49
+4.11 (1.04%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.